From the Bench, Summer 2025: In Vivo Treatment Spies to Counter Cancer’s Cunning
The summer, espionage-themed edition of From the Bench highlights in vivo cancer therapies that spring into action inside the...
The summer, espionage-themed edition of From the Bench highlights in vivo cancer therapies that spring into action inside the...
Yesterday, Onivyde, which is a nanotherapeutic form of the conventional chemotherapeutic irinotecan, was approved by the U.S. Food and...